The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The prospective MammaPrint MINT (Multi-Institutional Neo-adjuvant Therapy) study.
Charles E. Cox
No relevant relationships to disclose
Peter William Blumencranz
Consultant or Advisory Role - Agendia
Honoraria - Agendia
Ruben A. Saez
No relevant relationships to disclose
Robert Wesolowski
No relevant relationships to disclose
Lisette Stork
Employment or Leadership Position - Agendia
Femke De Snoo
Employment or Leadership Position - Agendia
Jessica Gibson
Employment or Leadership Position - Agendia
Nicole Howard
No relevant relationships to disclose
Eli Avisar
No relevant relationships to disclose